| 16S rRNA PCR | 16S polymerase chain reaction, ribosomal RNA gene |
| AFB | Acid-fast bacilli |
| CD4 | Cluster of differentiation 4 (T-lymphocyte surface marker) |
| CI | Confidence interval |
| CRP | C-reactive protein |
| CT | Computed tomography |
| DNA | Deoxyribonucleic acid |
| DST | Drug susceptibility testing |
| ESR | Erythrocyte sedimentation rate |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HIV | Human immunodeficiency virus |
| IDSA | Infectious Diseases Society of America |
| IGRA | Interferon-gamma release assay |
| MDR | Multidrug-resistant |
| mNGS | Metagenomic next-generation sequencing |
| MRI | Magnetic resonance imaging |
| NGS | Next-generation sequencing |
| NLR | Neutrophil-to-lymphocyte ratio |
| PCR | Polymerase chain reaction |
| PLR | Platelet-to-lymphocyte ratio |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PS | Pyogenic spondylodiscitis |
| QUADAS-2 | Quality Assessment of Diagnostic Accuracy Studies 2 |
| ROBINS-I | Risk Of Bias In Non-randomized Studies of Interventions |
| SPILF | Société de Pathologie Infectieuse de Langue Française (French Infectious Diseases Society) |
| TB | Tuberculosis |
| tNGS | Targeted next-generation sequencing |
| TS | Tuberculous spondylodiscitis |
| WBC | White blood cell count |
| Xpert Ultra | Xpert MTB/RIF Ultra(Cepheid; rapid nucleic acid amplification test for Mycobacterium Tuberculosis and rifampicin resistance) |
| WHO | World Health Organization |